Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

What’s new in the pathogenesis and treatment of therapy-related myeloid neoplasms

Maria Teresa Voso, Giulia Falconi, Emiliano Fabiani

Blood (2021) 138 (9): 749–757.

https://doi.org/10.1182/blood.2021010764

Published: 2021

Journal Articles

BRCA1 & BRCA2 Germline Variants Are Enriched in MDS/AML and Portend Higher Average Mutational Burden

Louis Williams, MD MBA, Teodora Kuzmanovic, BA, Cassandra M. Hirsch, Bartlomiej P. Przychodzen, Yogenthiran Saunthararajah, MD, Hassan Awada, MD, Vera Adema, PhD, Amy C Graham, BS, MS, Tomas Radivoyevitch, PhD, Hetty E. Carraway, MD MBA, Aziz Nazha, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski

Blood (2018) 132 (Supplement 1): 4352.

https://doi.org/10.1182/blood-2018-99-116802

Published: 2018

Journal Articles

Systematic Screening for Familial Leukemia Based on Somatic Genomic Profiling Results

Ensi Voshtina, DO, Arun K Singavi, MD, Amanda Jacquart, MS, CGC, Lyndsey Runaas, MD, Ehab L. Atallah, MD, Laura C. Michaelis, MD, Sameem Abedin, MD

Blood (2018) 132 (Supplement 1): 2253.

https://doi.org/10.1182/blood-2018-99-117020

Published: 2018

Journal Articles

Potential Familial Predisposition to Hematologic Neoplasm Detected Incidentally in Adult Patients Presenting with Myeloid Neoplasms

Vincent Funari, PhD, Maya Thangavelu, PhD, Wanlong Ma, MS, Ivan De Dios, BS, Sally Agersborg, MD PhD, Forrest Blocker, PhD, Maher Albitar, MD

Blood (2017) 130 (Supplement 1): 585.

https://doi.org/10.1182/blood.V130.Suppl_1.585.585

Published: 2017

Journal Articles

Disparate Mutations in B-Acute Lymphoblastic Leukemia Among African American and European American Children

Amit Reddy, MBBS, Ingrid Espinoza, PhD, Dana Cole, RN, Jason Schallheim, MD, Eldrin Bhanat, MPH, Yunyun Zhou, PhD, Jovanny Zabaleta, PhD, Gail Megason, MD, Christian Gomez, PhD

Blood (2017) 130 (Supplement 1): 5127.

https://doi.org/10.1182/blood.V130.Suppl_1.5127.5127

Published: 2017

Journal Articles

Germline ERBB2 Variants Associate with Myeloproliferative Neoplasms

Evan M Braunstein, MDPhD, Donna Marie Williams, PhD, Igor Makhlin, MD, Aparna Pallavajjala, Christopher D Gocke, MD, Nara Sobreira, MD, Kala Visvanathan, MD, Linda Resar, MD, Jerry L. Spivak, MD, Alison R. Moliterno, MD

Blood (2017) 130 (Supplement 1): 1663.

https://doi.org/10.1182/blood.V130.Suppl_1.1663.1663

Published: 2017

Journal Articles

A Story about a Mother with Chronic Lymphocytic Leukemia after Chronic Phase of Chronic Myeloid Leukemia and Her Daughter with Chronic Myeloid Leukemia: Case Report and Literature Review

Qi Wei, MD, Yongqiang Wei, MD, Xiaolei Wei, Xiaofang LI, MD, Hui Liu, MD, Ru Feng, MD

Blood (2017) 130 (Supplement 1): 5265.

https://doi.org/10.1182/blood.V130.Suppl_1.5265.5265

Published: 2017

Journal Articles

Genetic Profile and Novel Thrombospondin-1(THBS1) Mutation of Familial AML Syndrome: A Genomic Analysis By Whole Genome Sequencing and Whole Transcriptome Sequencing

Daeyoon Kim, Youngil Koh, MD, Jeonghwan Youk, Kwang-Sung Ahn, PhD, Hwi-Joong Yoon, MD, PhD, Hyun Jung Lee, MD, Hyo Jung Kim, MD PhD, Junglim Lee, MD, Sung-Soo Yoon, MDPhD

Blood (2015) 126 (23): 2595.

https://doi.org/10.1182/blood.V126.23.2595.2595

Published: 2015

Journal Articles

Downregulation of BAP1 in Chronic Myelomonocytic Leukemia: Correlated with a Post-Translational Reduction of BRCA1 Levels and Independent of Promoter Methylation

Ana María Hurtado, Gines Luengo-Gil, Laura Palomo, MSc, Eva Lumbreras, Eva Caparrós, Tzu Hua Chen-Liang, Bartlomiej Przychodzen, MSc, Maria Luz Amigo, María Díez-Campelo, MD PhD, Lurdes Zamora, PhD, Francisco José Ortuño, Raul Teruel Montoya, PhD, Jaroslaw P. Maciejewski, MD PhD, Consuelo Del Cañizo, MD PhD, Francesc Sole, PhD, Francisca Ferrer-Marin, Andres Jerez

Blood (2015) 126 (23): 1648.

https://doi.org/10.1182/blood.V126.23.1648.1648

Published: 2015

Journal Articles

BRCA1-Down-Regulation In Chronic Myeloid Leukemia (CML) Occurs Via The Deubiquitinase / Tumor Suppressor BRCA1-Associated Protein 1 (BAP1)

Fatima Dkhissi, PhD, Djamel Aggoune, Julien Pontis, Marie Laure Bonnet, Marie Claude Meunier, Nathalie Sorel, PhD, Clémentine Bouneau, Annelise Bennaceur-Griscelli, MD, PhD, François Guilhot, MD, Jean-Claude Chomel, PharmD, PhD, Slimane Ait-Si-Ali, PhD, Ali G Turhan, MD, PhD

Blood (2013) 122 (21): 3813.

https://doi.org/10.1182/blood.V122.21.3813.3813

Published: 2013

Journal Articles

Germline Mutations in CBL Cause a Predisposition to Juvenile Myelomonocytic Leukemia.

Blood (2009) 114 (22): 310.

https://doi.org/10.1182/blood.V114.22.310.310

Published: 2009

Journal Articles

Family History of Cancer and Risk of Lymphoma: Influence of IL8RB, GGH IVS7 and IL10 Polymorphisms.

Eva Domingo-Domènech, MD, Yolanda Benavente, Carlos Montalbán, PHD, Ramon Bosch, MD, Josep Gumà, MD, Sophia Wang, Nathaniel Rothman, Eva Gonzalez-Barca, Silvia de Sanjose, MD, PhD

Blood (2008) 112 (11): 1777.

https://doi.org/10.1182/blood.V112.11.1777.1777

Published: 2008

Journal Articles

Familial Malignant Hematological Disorders: A Systematic Assessment in 216 Consecutive Patients with Acute Leukaemia.

Laetitia Huiart, MD, Marina Lafage, MD, Laetitia Rabayrol, MD, Aude Charbonnier, MD, Philippe Bourdeleau, MD, Daniele Sainty, MD, Diane Coso, MD, Marie Joelle Mozziconacci, MD, Christine Arnoulet, MD, Anne-Marie Stoppa, MD, Anne Murati, MD, Marie Pascale Lehucher-Michel, MD, Hagay Sobol, MD, François Esinger, MD, Norbert Vey, MD

Blood (2006) 108 (11): 4500.

https://doi.org/10.1182/blood.V108.11.4500.4500

Published: 2006

Journal Articles

Paradoxical secondary polycythemia in von Hippel-Lindau patients treated with anti–vascular endothelial growth factor receptor therapy

Stéphane Richard, Laure Croisille, Jeannine Yvart, Nicole Casadeval, Pascal Eschwège, Nozar Aghakhani, Philippe David, Alain Gaudric, Paul Scigalla, Olivier Hermine

Blood (2002) 99 (10): 3851–3853.

https://doi.org/10.1182/blood.V99.10.3851

Published: 2002

NARROW

What’s new in the pathogenesis and treatment of therapy-related myeloid neoplasms

BRCA1 & BRCA2 Germline Variants Are Enriched in MDS/AML and Portend Higher Average Mutational Burden

Systematic Screening for Familial Leukemia Based on Somatic Genomic Profiling Results

Potential Familial Predisposition to Hematologic Neoplasm Detected Incidentally in Adult Patients Presenting with Myeloid Neoplasms

Disparate Mutations in B-Acute Lymphoblastic Leukemia Among African American and European American Children

Germline ERBB2 Variants Associate with Myeloproliferative Neoplasms

A Story about a Mother with Chronic Lymphocytic Leukemia after Chronic Phase of Chronic Myeloid Leukemia and Her Daughter with Chronic Myeloid Leukemia: Case Report and Literature Review

Genetic Profile and Novel Thrombospondin-1(THBS1) Mutation of Familial AML Syndrome: A Genomic Analysis By Whole Genome Sequencing and Whole Transcriptome Sequencing

Downregulation of BAP1 in Chronic Myelomonocytic Leukemia: Correlated with a Post-Translational Reduction of BRCA1 Levels and Independent of Promoter Methylation

BRCA1-Down-Regulation In Chronic Myeloid Leukemia (CML) Occurs Via The Deubiquitinase / Tumor Suppressor BRCA1-Associated Protein 1 (BAP1)

Germline Mutations in CBL Cause a Predisposition to Juvenile Myelomonocytic Leukemia.

Family History of Cancer and Risk of Lymphoma: Influence of IL8RB, GGH IVS7 and IL10 Polymorphisms.

Familial Malignant Hematological Disorders: A Systematic Assessment in 216 Consecutive Patients with Acute Leukaemia.

Paradoxical secondary polycythemia in von Hippel-Lindau patients treated with anti–vascular endothelial growth factor receptor therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only